AGN (+5%) sets all-time intraday and closing highs. The stock has been strong ever since JNJ dropped development of PurTox, a Botox competitor (#msg-100466796), but today’s sharp move was presumably predicated by something else such as a buyout rumor.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”